This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

MBCC’s admixture research centers, patents and trademarks part of Sika’s remedy package to UK regulator (update*)

By Nicholas Hirst ( October 25, 2022, 09:23 GMT | Insight) -- Swiss chemical company Sika has told the UK competition authority that it is prepared to sell R&D centers in Germany, Italy and the US as part of a wider package of  admixture assets across a series of countries to ease global competition concerns over its $5.9 billion acquisition of chemical rival MBCC. The package also includes all of the target’s entire business in Australia and New Zealand.* MBCC sells chemical admixture systems as well as products used in construction, such as industrial flooring, waterproofing and adhesives.Swiss chemical company Sika has told the UK competition authority that it is prepared to sell R&D centers in Germany, Italy and the US as part of a wider package of admixture assets across dozens of countries to ease global competition concerns over its $5.9 billion acquisition of chemical rival MBCC.*...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login